Andrew Johnson Defends Thesis

Andrew Johnson successfully passed his Ph.D. examination on Friday, February 17, 2012. His thesis title was "Protection against Angiotensin II-induced Endothelial Dysfunction and Hypertension via Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (STAT3)". Members of his thesis committee were chair, Frank Faraci from the Departments of Internal Medicine and Pharmacology; Yuriy Usachev from the Departments of Pharmacology and Anesthesia; Don Heistad and Kathryn Lamping from the Departments of Internal Medicine and Pharmacology and Gary Baumbach from the Department of Pathology.

Dr. Johnson's research focused on the role of STAT3 in vascular disease and hypertension. He received his B.S. in Biology and M.S. in Biochemistry & Biology from the University of Missouri in St. Louis, MO and began in the Pharmacology Ph.D. Program at Iowa in 2006. During research in Dr. Faraci's laboratory, Dr. Johnson received an American Heart Association Predoctoral Fellowship for two years. Immediate plans are to start a postdoctoral position at Washington University in Dr. Greg Zipfel's lab, where he will study mechanisms that account for vascular abnormalities in the brain in models of Alzheimer’s disease.

Congratulations to Dr. Johnson!